[Pericardial effusion associated with interferon therapy].
Cervera Miguel
Juan Ignacio
JI
Vallalta
Manuel
M
Iranzo
Esther
E
Navarro Ibáñez
Vicente
V
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D010490:Pericardial Effusion / Q000139:chemically induced*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a